Automated prediction of dosimetric eligibility for hypofractionated prostate radiotherapy

Clinical implementation of hypofractionated prostate radiotherapy (PROFIT trial, NCT003046759) represents an opportunity to significantly reduce the burden of treatment on the patient and clinic. However, efficacy was only demonstrated among the patient demographic who could meet the trial dose cons...

Descripción completa

Detalles Bibliográficos
Autores principales: Lausch, Anthony, Lamey, Michael, Zeng, Grace G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Radiation Oncology Physics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689926/
https://www.ncbi.nlm.nih.gov/pubmed/28980442
http://dx.doi.org/10.1002/acm2.12198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689926/
https://www.ncbi.nlm.nih.gov/pubmed/28980442
http://dx.doi.org/10.1002/acm2.12198

Ejemplares similares